Comparison of Survival Rates in Patients with Metastatic Renal Cell Carcinoma According to Treatment Era Including Cytokine and Targeted Therapy

By Takagi Toshio   Kondo Tsunenori   Kennoki Takafumi   Iizuka Jyunpei   Kobayashi Hirohito   Hashimoto Yasunobu   Tanabe Kazunari  

Japanese Journal of Clinical Oncology, Vol. 43, Iss. 4, 2013-04 ,pp. : 439-443

Oxford University Press

Access to resources Recommend Favorite

Prognostic significance of C-reactive protein in patients with intermediate-risk metastatic renal cell carcinoma treated with molecular targeted therapy

By                            

Oncology Letters, Vol. 8, Iss. 2, 2014-01 ,pp. : 881-885

Spandidos Publications

Access to resources Recommend Favorite

Predicting outcome to VEGF-targeted therapy in metastatic clear-cell renal cell carcinoma: data from recent studies

By Golshayan Ali-Reza   Brick Ashley J   Choueiri Toni K  

Future Oncology, Vol. 4, Iss. 1, 2008-02 ,pp. : 85-92

Future Medicine

Access to resources Recommend Favorite

Prognostic outcome in patients treated with tyrosine kinase inhibitors as first-line molecular-targeted therapy for metastatic renal cell carcinoma: Experience in real-world clinical practice in Japan

By          

Molecular and Clinical Oncology, Vol. 3, Iss. 3, 2015-01 ,pp. : 601-606

Science Publishers

Access to resources Recommend Favorite

Current and predicted cost of metastatic renal cell carcinoma in Finland

By Purmonen Timo   Nuttunen Päivi   Vuorinen Riikka   Pyrhönen Seppo   Kataja Vesa   Kellokumpu-Lehtinen Pirkko  

Acta Oncologica, Vol. 49, Iss. 6, 2010-08 ,pp. : 837-843

Informa Healthcare

Access to resources Recommend Favorite